Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Christopher Kane

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentUrology
    Address200 W. Arbor Drive #8897
    CA San Diego 92103
    Phone619-543-2626
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Christopher J. Kane is a specialist in prostate cancer and an expert in robotic and other minimally invasive procedures for urologic surgery.

      Named a 2014 “Top Doc" in San Diego Magazine’s “Physicians of Exceptional Excellence" annual survey performed in collaboration with the San Diego County Medical Society, Dr. Kane is internationally recognized for his patient care and research in prostate cancer, renal cell carcinoma, and minimally invasive surgical treatment of urologic diseases and disorders.

      Dr. Kane is an expert in robotic prostatectomy, open and laparoscopic kidney cancer surgery and bladder and testes cancer surgery. He has authored more than 220 publications and book chapters primarily on prostate cancer risk factors and outcomes, prostate cancer surgery and minimally invasive surgery for prostate and kidney cancer. He has taught laparoscopy and robotic surgery extensively and started the robotic surgery program at UC San Francisco and at the VA Medical Center San Francisco in 2002.

      He performs over 200 robotic cancer surgeries per year and is highly experienced in nerve sparing robotic prostatectomies, robotic radical cystectomy for bladder cancer and robotic partial nephrectomy for kidney cancer.

      To make an appointment with Dr. Kane, please call: 858-822-6187


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Teeter AE, Griffin K, Howard LE, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Freedland SJ. Does early PSADT (ePSADT) after Radical Prostatectomy, Calculated prior to PSA Recurrence, Correlate with Prostate Cancer Outcomes? -A Report from the SEARCH Database Group. J Urol. 2017 Sep 01. PMID: 28870860.
        View in: PubMed
      2. Stroup SP, Moreira DM, Chen Z, Howard L, Berger JH, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane C, Freedland SJ. Biopsy-Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis, and Mortality in a Cohort of Men with High-Risk Prostate Cancer. J Urol. 2017 Jul 11. PMID: 28709888.
        View in: PubMed
      3. Schulman AA, Howard LE, Tay KJ, Tsivian E, Sze C, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Freedland SJ, Polascik TJ. Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system. Cancer. 2017 Jun 29. PMID: 28662291.
        View in: PubMed
      4. McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Freedland SJ. Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2017 Aug; 24(8):611-617. PMID: 28589550.
        View in: PubMed
      5. Howard LE, Moreira D, De Hoedt A, Aronson WJ, Kane C, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer. BJU Int. 2017 Mar 28. PMID: 28371163.
        View in: PubMed
      6. Kane C, Eggener SE, Shindel AW, Andriole GL. Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review. Eur Urol Focus. 2017 Mar 11. PMID: 28753804.
        View in: PubMed
      7. Lee HJ, Barback CV, Hoh CK, Zhengtao Q, Kareem K, David HJ, Vera DR, Kane C. Bi-Modal Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 Feb 02. PMID: 28153955.
        View in: PubMed
      8. Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Freedland SJ. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer. Cancer. 2016 Dec 27. PMID: 28026865.
        View in: PubMed
      9. Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Spratt DE, Sandler HM, Freedland SJ. Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database. Prostate. 2017 Feb; 77(2):154-163. PMID: 27683213.
        View in: PubMed
      10. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 Sep 29. PMID: 27688020.
        View in: PubMed
      11. Whitney CA, Howard LE, Posadas EM, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Freedland SJ. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. Eur Urol Focus. 2016 Aug 29. PMID: 28753787.
        View in: PubMed
      12. Whitney CA, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Freedland SJ. Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer. Cancer. 2016 Dec 15; 122(24):3848-3855. PMID: 27505036.
        View in: PubMed
      13. Lee HJ, Yousefi K, Haddad Z, Abdollah F, Lam LL, Shin H, Alshalalfa M, Godebu E, Wang S, Shabaik A, Davicioni E, Kane C. Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis. Res Rep Urol. 2016; 8:77-84. PMID: 27419104.
        View in: PubMed
      14. Leapman MS, Freedland SJ, Aronson WJ, Kane C, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 Nov; 196(5):1408-1414. PMID: 27352635.
        View in: PubMed
      15. McDonald ML, Liss MA, Nseyo UU, Gal DB, Kane C, Kader AK. Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival. Clin Genitourin Cancer. 2017 Feb; 15(1):86-92. PMID: 27460433.
        View in: PubMed
      16. Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Aronson WJ, Kane C, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ. Predictors of Time to Metastasis in Castration-resistant Prostate Cancer. Urology. 2016 Oct; 96:171-176. PMID: 27318265.
        View in: PubMed
      17. Yamin G, Schenker-Ahmed NM, Shabaik A, Adams D, Bartsch H, Kuperman J, White NS, Rakow-Penner RA, McCammack K, Parsons JK, Kane C, Dale AM, Karow DS. Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer. Clin Cancer Res. 2016 Jun 1; 22(11):2668-74. PMID: 27250935.
        View in: PubMed
      18. McCammack KC, Schenker-Ahmed NM, White NS, Best SR, Marks RM, Heimbigner J, Kane C, Parsons JK, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Liss MA, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS. Restriction spectrum imaging improves MRI-based prostate cancer detection. Abdom Radiol (NY). 2016 May; 41(5):946-53. PMID: 26910114.
        View in: PubMed
      19. Patel N, Woo J, Liss MA, Palazzi KL, Randall JM, Mehrazin R, Jabaj R, Mirheydar HS, Gillis K, Lee HJ, Patterson AL, Kane C, Millard F, Derweesh IH. Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches. Can J Urol. 2016 Apr; 23(2):8227-33. PMID: 27085828.
        View in: PubMed
      20. Gaylis F, Cohen E, Calabrese R, Prime H, Dato P, Kane C. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve? Urology. 2016 Jul; 93:60-7. PMID: 26876460.
        View in: PubMed
      21. Freedland SJ, Howard LE, Hanyok BT, Kadiyala VK, Kuang JY, Whitney CA, Wilks FR, Kane C, Terris MK, Amling CL, Cooperberg MR, Aronson WJ, Moreira DM. Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer. BJU Int. 2016 Oct; 118(4):570-7. PMID: 26762961.
        View in: PubMed
      22. Allott EH, Howard LE, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Freedland SJ. Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):547-54. PMID: 26809276.
        View in: PubMed
      23. McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Freedland SJ. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2016 Mar; 23(3):241-6. PMID: 26667212.
        View in: PubMed
      24. Hanyok BT, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane C, Terris MK, Posadas EM, Freedland SJ. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer. 2016 Jan 15; 122(2):222-9. PMID: 26484853.
        View in: PubMed
      25. Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane C, Freedland SJ. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer-Results from the SEARCH database. Cancer Epidemiol. 2015 Dec; 39(6):1066-70. PMID: 26452418.
        View in: PubMed
      26. Hamilton ZA, Kane C. Nerve-sparing Technique During Radical Prostatectomy and its Effect on Urinary Continence. Eur Urol. 2016 Apr; 69(4):590-1. PMID: 26320380.
        View in: PubMed
      27. Liss MA, Kane C, Chen T, Baumgartner J, Derweesh IH. Virtual reality suturing task as an objective test for robotic experience assessment. BMC Urol. 2015; 15:63. PMID: 26137869.
        View in: PubMed
      28. Raheem OA, Cohen SA, Parsons JK, Palazzi KL, Kane C. A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy. Sci Rep. 2015; 5:10544. PMID: 26112134.
        View in: PubMed
      29. Mithal P, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Kane C, Amling C, Freedland SJ. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. BJU Int. 2016 Feb; 117(2):244-8. PMID: 26010160.
        View in: PubMed
      30. Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Vidal AC. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted? BJU Int. 2016 Jun; 117(6):897-903. PMID: 26010251.
        View in: PubMed
      31. Ovadia AE, Terris MK, Aronson WJ, Kane C, Amling CL, Cooperberg MR, Freedland SJ, Abern MR. Agent Orange and long-term outcomes after radical prostatectomy. Urol Oncol. 2015 Jul; 33(7):329.e1-6. PMID: 25998746.
        View in: PubMed
      32. Haas NB, Manola J, Ky B, Flaherty KT, Uzzo RG, Kane C, Jewett M, Wood L, Wood CG, Atkins MB, Dutcher JJ, Wilding G, DiPaola RS. Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805. Clin Cancer Res. 2015 Sep 15; 21(18):4048-54. PMID: 25967143.
        View in: PubMed
      33. Zelones J, Kiyama L, Sandler BJ, Kane C. Sigmoid Perforation due to Toothpick Ingestion Leading to Hydronephrosis and Urosepsis. Am Surg. 2015 May; 81(5):232-3. PMID: 25975321.
        View in: PubMed
      34. Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, Jamieson C, Kane C, Klatte T, Birner P, Kenner L, Karin M. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015 May 7; 521(7550):94-8. PMID: 25924065.
        View in: PubMed
      35. Zapata DF, Howard LE, Aronson WJ, Kane C, Terris MK, Amling CL, Cooperberg MR, Freedland SJ. Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2015 Jul; 22(7):658-62. PMID: 25872110.
        View in: PubMed
      36. Mithal P, Howard LE, Aronson WJ, Kane C, Cooperberg MR, Terris MK, Amling CL, Freedland SJ. Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2015 Apr; 22(4):362-6. PMID: 25728968.
        View in: PubMed
      37. Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, Kane C, Reiter RE, Dale AM, Karow DS. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens. Front Oncol. 2015; 5:30. PMID: 25741473.
        View in: PubMed
      38. Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane C, Partin A, Han M, Freedland SJ. Is clinical stage T2c prostate cancer an intermediate- or high-risk disease? Cancer. 2015 May 1; 121(9):1414-21. PMID: 25492369.
        View in: PubMed
      39. Sourbeer KN, Howard LE, Moreira DM, Amarasekara HS, Chow LD, Cockrell DC, Hanyok BT, Pratson CL, Kane C, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Hernandez RK, Freedland SJ. Practice Patterns and Predictors of Followup Imaging after a Negative Bone Scan in Men with Castration Resistant Prostate Cancer: Results from the SEARCH Database. J Urol. 2015 Apr; 193(4):1232-8. PMID: 25463986.
        View in: PubMed
      40. Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane C, Sur RL. What is the Incidence of Kidney Stones after Chemotherapy in Patients with Lymphoproliferative or Myeloproliferative Disorders? Int Braz J Urol. 2014 Nov-Dec; 40(6):772-80. PMID: 25615245.
        View in: PubMed
      41. Allott EH, Howard LE, Cooperberg MR, Kane C, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2349-56. PMID: 25304929.
        View in: PubMed
      42. Lee HJ, Kane C. How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy. Curr Urol Rep. 2014 Oct; 15(10):445. PMID: 25129450.
        View in: PubMed
      43. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane C. Robotic-assisted Fluorescence Sentinel Lymph Node Mapping Using Multimodal Image Guidance in an Animal Model. Urology. 2014 Oct; 84(4):982.e9-982.e14. PMID: 25139676.
        View in: PubMed
      44. Liss MA, Chen H, Hemal S, Krane S, Kane C, Xu J, Kader AK. Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening. J Urol. 2015 Jan; 193(1):75-9. PMID: 25066872.
        View in: PubMed
      45. Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, Kane C, Wake RW, Patterson AL, Wan JY, Derweesh IH. Impact of renal surgery for cortical neoplasms on lipid metabolism. BJU Int. 2014 Dec; 114(6):837-43. PMID: 24656182.
        View in: PubMed
      46. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane C, Vera DR. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. PMID: 25024425.
        View in: PubMed
      47. Godebu E, Woldrich JM, Cohen SA, Kane C, Owens EL, Sakamoto K. Incorporating robot-assisted prostatectomy at a veterans affairs hospital: outcomes. J Endourol. 2014 Sep; 28(9):1097-102. PMID: 24819015.
        View in: PubMed
      48. Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane C, Kader AK. Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort. Urology. 2014 Aug; 84(2):314-20. PMID: 24958477.
        View in: PubMed
      49. Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane C, Kader AK. Reply. Urology. 2014 Aug; 84(2):319-20. PMID: 24958489.
        View in: PubMed
      50. Kane C. Editorial comment. Urology. 2014 Jun; 83(6):1367-8. PMID: 24862396.
        View in: PubMed
      51. Allott EH, Howard LE, Cooperberg MR, Kane C, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2014 Nov; 114(5):661-6. PMID: 24588774.
        View in: PubMed
      52. Abern MR, Terris MK, Aronson WJ, Kane C, Amling CL, Cooperberg MR, Freedland SJ. The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer. Cancer. 2014 Jun 1; 120(11):1656-62. PMID: 24647966.
        View in: PubMed
      53. Woo JR, Liss MA, Muldong MT, Palazzi K, Strasner A, Ammirante M, Varki N, Shabaik A, Howell S, Kane C, Karin M, Jamieson CA. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med. 2014; 12(1):30. PMID: 24475900.
        View in: PubMed
      54. Moreira DM, Aronson WJ, Terris MK, Kane C, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database. Cancer. 2014 Jan 15; 120(2):197-204. PMID: 24127391.
        View in: PubMed
      55. Woo JR, Liss MA, Kane C. Laparoscopic removal of spermatic cord to reduce incision size of open retroperitoneal lymph node dissection. Urology. 2013 Oct; 82(4):959-62. PMID: 24074990.
        View in: PubMed
      56. Cohen SA, Kane C, Juwono T, Masterson JH, Kaplan GW. Urology in San Diego--its history in "America's finest city". Urology. 2013 Aug; 82(2):280-3. PMID: 23896091.
        View in: PubMed
      57. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. Urology. 2013 Jul; 82(1):53-8. PMID: 23806388.
        View in: PubMed
      58. Bazzi WM, Stroup SP, Cohen SA, Sisul DM, Liss MA, Masterson JH, Kopp RP, Gudeman SR, Leeflang E, Palazzi KL, Ramamoorthy S, Kane C, Horgan S, Derweesh IH. Comparison of transrectal and transvaginal hybrid natural orifice transluminal endoscopic surgery partial nephrectomy in the porcine model. Urology. 2013 Jul; 82(1):84-9. PMID: 23676357.
        View in: PubMed
      59. Moreira DM, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. Int Braz J Urol. 2013 May-Jun; 39(3):312-8; discussion 319. PMID: 23849564.
        View in: PubMed
      60. Liss MA, Kane C. Editorial Comment from Dr Liss and Dr Kane to Lymphocele after extraperitoneal robot-assisted radical prostatectomy: A propensity score-matching study. Int J Urol. 2013 Dec; 20(12):1177. PMID: 23586475.
        View in: PubMed
      61. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Carroll PR, Cooperberg MR. Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. PMID: 23587869.
        View in: PubMed
      62. Liss MA, Palazzi K, Stroup SP, Jabaji R, Raheem OA, Kane C. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy. World J Urol. 2013 Jun; 31(3):481-8. PMID: 23512231.
        View in: PubMed
      63. Stroup SP, Raheem OA, Palazzi KL, Liss MA, Mehrazin R, Kopp RP, Patel N, Cohen SA, Park SK, Patterson AL, Kane C, Millard F, Derweesh IH. Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study. Urology. 2013 Apr; 81(4):805-11. PMID: 23414694.
        View in: PubMed
      64. Kane C. Commentary on "impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy." Campeggi A, Xylinas E, Ploussard G, Ouzaid I, Fabre A, Allory Y, Vordos D, Abbou CC, Salomon L, de la Taille A, Institut National de la Sante et de la Recherche Medicale Unit 955 EQ7, Department of Urology, APHP, CHU Henri Mondor, Créteil, France: Urology 2012;80(3):576-84. Urol Oncol. 2013 Feb; 31(2):274-5. PMID: 23465475.
        View in: PubMed
      65. Wu C, Aronson WJ, Terris MK, Presti JC, Kane C, Amling CL, Freedland SJ. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database. BJU Int. 2013 Jun; 111(8):E310-8. PMID: 23305170.
        View in: PubMed
      66. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane C, Wallace AM, Vera DR. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013; 18(10):101315. PMID: 23958947.
        View in: PubMed
      67. Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane C, Amling CL, Freedland SJ. Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer-Specific Outcomes: Results from the SEARCH Database. Eur Urol. 2014 Mar; 65(3):620-7. PMID: 23245686.
        View in: PubMed
      68. Abern MR, Aronson WJ, Terris MK, Kane C, Presti JC, Amling CL, Freedland SJ. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database. Prostate. 2013 Mar; 73(4):409-17. PMID: 22996686.
        View in: PubMed
      69. Bazzi WM, Stroup SP, Cohen SA, Dotai T, Kopp RP, Colangelo C, Raheem OA, Ramamoorthy S, Talamini M, Horgan S, Kane C, Derweesh IH. Feasibility of transrectal hybrid natural orifice transluminal endoscopic surgery (NOTES) nephrectomy in the cadaveric model. Urology. 2012 Sep; 80(3):590-5. PMID: 22925236.
        View in: PubMed
      70. Ho T, Gerber L, Aronson WJ, Terris MK, Presti JC, Kane C, Amling CL, Freedland SJ. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol. 2012 Nov; 62(5):910-6. PMID: 22921964.
        View in: PubMed
      71. Kopp RP, Dicks BM, Goldstein I, Mehrazin R, Silberstein JL, Colangelo CJ, Bagrodia A, Bazzi WM, Wake RW, Patterson AL, Kane C, Wan JY, Derweesh IH. Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis. BJU Int. 2013 Mar; 111(3 Pt B):E98-102. PMID: 22757628.
        View in: PubMed
      72. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane C, Wallace AM, Vera DR. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. PMID: 22753678.
        View in: PubMed
      73. Kane C. Robotic prostatectomy improves outcomes--after the potentially risky adoption phase. Oncology (Williston Park). 2012 Jul; 26(7):626, 628, 630. PMID: 22888562.
        View in: PubMed
      74. Stroup SP, Kane C, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. PMID: 22714690.
        View in: PubMed
      75. Raheem OA, Bazzi WM, Parsons JK, Kane C. Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy. Urol Ann. 2012 May; 4(2):111-4. PMID: 22629010.
        View in: PubMed
      76. Kopp RP, Stroup SP, Schroeck FR, Freedland SJ, Millard F, Terris MK, Aronson WJ, Presti JC, Amling CL, Kane C. Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. J Urol. 2012 Jun; 187(6):2056-60. PMID: 22498218.
        View in: PubMed
      77. Muller RL, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database. Urology. 2012 May; 79(5):1105-10. PMID: 22446345.
        View in: PubMed
      78. Chu DI, Moreira DM, Gerber L, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer. 2012 Oct 15; 118(20):4999-5007. PMID: 22415377.
        View in: PubMed
      79. Nowfar S, Kopp R, Palazzi-Churas K, Derweesh IH, Kane C. Initial experience with aspirin use during robotic radical prostatectomy. J Laparoendosc Adv Surg Tech A. 2012 Apr; 22(3):225-9. PMID: 22393926.
        View in: PubMed
      80. Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane C, Amling CL, Freedland SJ. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. BJU Int. 2012 Aug; 110(4):492-8. PMID: 22094083.
        View in: PubMed
      81. Raheem O, Kulidjian AA, Wu C, Jeong YB, Yamaguchi T, Smith KM, Goff D, Leu H, Morris SR, Cacalano NA, Masuda K, Jamieson CH, Kane C, Jamieson CA. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions. J Transl Med. 2011; 9:185. PMID: 22035283.
        View in: PubMed
      82. Stroup SP, Kane C. Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature. ISRN Urol. 2011; 2011:201408. PMID: 22084791.
        View in: PubMed
      83. Woldrich J, Mehrazin R, Bazzi WM, Bagrodia A, Kopp RP, Malcolm JB, Kane C, Patterson AL, Wan JY, Derweesh IH. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy. BJU Int. 2012 Apr; 109(7):1019-25. PMID: 21933323.
        View in: PubMed
      84. Bazzi WM, Raheem OA, Stroup SP, Kane C, Derweesh IH, Downs TM. Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review. Urol Ann. 2011 Sep; 3(3):115-8. PMID: 21976922.
        View in: PubMed
      85. Mohr SB, Gorham ED, Alcaraz JE, Kane C, Macera CA, Parsons JK, Wingard DL, Garland CF. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 2011 Sep; 31(9):2939-48. PMID: 21868542.
        View in: PubMed
      86. Kane C, Raheem OA, Bent S, Avins AL. What do I tell patients about saw palmetto for benign prostatic hyperplasia? Urol Clin North Am. 2011 Aug; 38(3):261-77. PMID: 21798388.
        View in: PubMed
      87. Bagrodia A, Mehrazin R, Bazzi WM, Silberstein J, Malcolm JB, Stroup SP, Raheem O, Wake RW, Kane C, Patterson AL, Wan JY, Derweesh IH. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. Urology. 2011 Sep; 78(3):614-9. PMID: 21777959.
        View in: PubMed
      88. Cooperberg MR, Mallin K, Kane C, Carroll PR. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. PMID: 21679982.
        View in: PubMed
      89. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group. Urology. 2011 Jan; 77(1):149-53. PMID: 21145094.
        View in: PubMed
      90. Breyer BN, Davis CB, Cowan JE, Kane C, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. PMID: 20438567.
        View in: PubMed
      91. Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane C, Derweesh IH. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int. 2010 Nov; 106(9):1270-6. PMID: 20394613.
        View in: PubMed
      92. Kim HS, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate. 2010 Oct 1; 70(14):1540-6. PMID: 20687228.
        View in: PubMed
      93. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Sun LL, Moul JW, Freedland SJ. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases. Int J Urol. 2010 Nov; 17(11):914-22. PMID: 20880361.
        View in: PubMed
      94. Kim HS, Moreira DM, Smith MR, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2011 Mar; 107(6):924-8. PMID: 20860651.
        View in: PubMed
      95. Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane C, Presti JC, Amling CL, Freedland SJ. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer. 2010 Jul 15; 116(14):3389-98. PMID: 20586112.
        View in: PubMed
      96. Derweesh IH, Silberstein JL, Bazzi W, Kopp R, Downs TM, Kane C. Laparo-endoscopic single-site surgery for radical and cytoreductive nephrectomy, renal vein thrombectomy, and partial nephrectomy: a prospective pilot evaluation. Diagn Ther Endosc. 2010; 2010:107482. PMID: 20631830.
        View in: PubMed
      97. Kane C, Im R, Amling CL, Presti JC, Aronson WJ, Terris MK, Freedland SJ. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology. 2010 Sep; 76(3):695-700. PMID: 20394969.
        View in: PubMed
      98. Moreira DM, Antonelli JA, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. Urology. 2010 Nov; 76(5):1218-23. PMID: 20381838.
        View in: PubMed
      99. Jayachandran J, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane C, Freedland SJ. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):9-17. PMID: 20056618.
        View in: PubMed
      100. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane C, Parsons JK, Mundt AJ. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 1; 78(2):435-41. PMID: 19939580.
        View in: PubMed
      101. Jayachandran J, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane C, Freedland SJ. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer. 2009 Nov 15; 115(22):5263-71. PMID: 19670453.
        View in: PubMed
      102. Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti JC, Terris MK, Kane C, Amling CL, Sun L, Freedland SJ. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy. BJU Int. 2010 Jun; 105(12):1654-9. PMID: 19912203.
        View in: PubMed
      103. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2010 Jun; 105(11):1541-7. PMID: 19912191.
        View in: PubMed
      104. Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane C, Amling CL, Presti JC. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. Urology. 2010 Feb; 75(2):439-44. PMID: 19819536.
        View in: PubMed
      105. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. J Urol. 2009 Nov; 182(5):2250-5. PMID: 19758614.
        View in: PubMed
      106. Kane C, Dicks B. Editorial comment. Urology. 2009 Sep; 74(3):617-8. PMID: 19716915.
        View in: PubMed
      107. Lloyd JC, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane C, Freedland SJ. Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database. BJU Int. 2010 Feb; 105(3):347-51. PMID: 19709073.
        View in: PubMed
      108. Cooperberg MR, Kane C, Cowan JE, Carroll PR. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Jan; 105(1):88-92. PMID: 19549119.
        View in: PubMed
      109. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group. BJU Int. 2009 Dec; 104(11):1604-9. PMID: 19549124.
        View in: PubMed
      110. Bañez LL, Sun L, Trock BJ, Han M, Partin AW, Aronson WJ, Terris MK, Presti JC, Kane C, Amling CL, Moul JW, Freedland SJ. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. J Urol. 2009 Aug; 182(2):491-6; discussion 496-8. PMID: 19524974.
        View in: PubMed
      111. Moreira DM, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int. 2010 Jan; 105(1):28-33. PMID: 19522861.
        View in: PubMed
      112. Moreira DM, Jayachandran J, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Stephenson AJ, Freedland SJ. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. BJU Int. 2009 Nov; 104(10):1452-6. PMID: 19466946.
        View in: PubMed
      113. Bañez LL, Terris MK, Aronson WJ, Presti JC, Kane C, Amling CL, Freedland SJ. Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1208-12. PMID: 19336564.
        View in: PubMed
      114. Shah SR, Freedland SJ, Aronson WJ, Kane C, Presti JC, Amling CL, Terris MK. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy. BJU Int. 2009 May; 103(9):1168-72. PMID: 19298411.
        View in: PubMed
      115. Silberstein J, Grabowski J, Saltzstein SL, Kane C. Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry. Pediatr Blood Cancer. 2009 Feb; 52(2):237-41. PMID: 18937317.
        View in: PubMed
      116. Schroeck FR, Aronson WJ, Presti JC, Terris MK, Kane C, Amling CL, Freedland SJ. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int. 2009 Mar; 103(5):603-8. PMID: 19021608.
        View in: PubMed
      117. Teeter AE, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane C, Amling CL, Freedland SJ. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. J Urol. 2008 Nov; 180(5):1980-4; discussion 1985. PMID: 18801519.
        View in: PubMed
      118. Turley RS, Terris MK, Kane C, Aronson WJ, Presti JC, Amling CL, Freedland SJ. The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database. BJU Int. 2008 Nov; 102(9):1074-9. PMID: 18778348.
        View in: PubMed
      119. Freedland SJ, Sun L, Kane C, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int. 2008 Sep; 102(8):969-74. PMID: 18691175.
        View in: PubMed
      120. Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int. 2008 Sep; 102(8):964-8. PMID: 18691176.
        View in: PubMed
      121. Kane C, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 1; 113(1):78-83. PMID: 18491376.
        View in: PubMed
      122. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane C, Perez N, Master VA, Carroll PR. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. PMID: 18433013.
        View in: PubMed
      123. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane C. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008 Jun; 179(6):2131-5. PMID: 18423754.
        View in: PubMed
      124. Dall'Era MA, Kane C. Watchful waiting versus active surveillance: appropriate patient selection. Curr Urol Rep. 2008 May; 9(3):211-6. PMID: 18765115.
        View in: PubMed
      125. Jayachandran J, Bañez LL, Levy DE, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane C, Freedland SJ. Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. J Urol. 2008 May; 179(5):1791-6; discussion 1796. PMID: 18343426.
        View in: PubMed
      126. Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane C. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008 May; 179(5):1709-13; discussion 1713. PMID: 18343430.
        View in: PubMed
      127. Hamilton RJ, Aronson WJ, Terris MK, Kane C, Presti JC, Amling CL, Freedland SJ. Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database. J Urol. 2008 May; 179(5):1785-9; discussion 1789-90. PMID: 18343434.
        View in: PubMed
      128. Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, Neuhaus J, Hudes E, Shinohara K, Kane C. A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008 Jun; 16(3):147-54. PMID: 18534327.
        View in: PubMed
      129. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane C. Effect of BMI on primary treatment of prostate cancer. Urology. 2008 Aug; 72(2):406-11. PMID: 18267336.
        View in: PubMed
      130. Turley RS, Hamilton RJ, Terris MK, Kane C, Aronson WJ, Presti JC, Amling CL, Freedland SJ. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol. 2008 Feb; 179(2):523-7; discussion 527-8. PMID: 18076952.
        View in: PubMed
      131. Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane C, Presti JC, Amling CL, Freedland SJ. The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. Urology. 2008 Jan; 71(1):151-5. PMID: 18242385.
        View in: PubMed
      132. Bañez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC, Kane C, Amling CL, Moul JW, Freedland SJ. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007 Nov 21; 298(19):2275-80. PMID: 18029831.
        View in: PubMed
      133. Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane C, Amling CL, Freedland SJ. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer. 2007 Nov 15; 110(10):2202-9. PMID: 17876838.
        View in: PubMed
      134. Ku TS, Kane C, Sen S, Henderson WG, Dudley RA, Cason BA. Effects of hospital procedure volume and resident training on clinical outcomes and resource use in radical retropubic prostatectomy surgery in the Department of Veterans Affairs. J Urol. 2008 Jan; 179(1):272-8; discussion 278-9. PMID: 18001784.
        View in: PubMed
      135. Buschemeyer WC, Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane C, Amling CL, Freedland SJ. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. J Urol. 2008 Jan; 179(1):124-9; discussion 129. PMID: 17997433.
        View in: PubMed
      136. Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane C, Terris MK, Aronson WJ, Amling CL. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Eur Urol. 2008 Apr; 53(4):758-64; discussion 765-6. PMID: 17868976.
        View in: PubMed
      137. Scales CD, Presti JC, Kane C, Terris MK, Aronson WJ, Amling CL, Freedland SJ. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. J Urol. 2007 Oct; 178(4 Pt 1):1249-52. PMID: 17698131.
        View in: PubMed
      138. Kang DE, Fitzsimons NJ, Presti JC, Kane C, Terris MK, Aronson WJ, Amling CL, Freedland SJ. Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. Urology. 2007 Aug; 70(2):277-82. PMID: 17826489.
        View in: PubMed
      139. Sajadi KP, Terris MK, Hamilton RJ, Cullen J, Amling CL, Kane C, Presti JC, Aronson WJ, Freedland SJ. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. J Urol. 2007 Sep; 178(3 Pt 1):990-5. PMID: 17632170.
        View in: PubMed
      140. Mavropoulos JC, Partin AW, Amling CL, Terris MK, Kane C, Aronson WJ, Presti JC, Mangold LA, Freedland SJ. Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? Urology. 2007 Jun; 69(6):1138-42. PMID: 17572202.
        View in: PubMed
      141. King CR, Freedland SJ, Terris MK, Kane C, Amling CL, Aronson WJ, Presti JC. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. Urology. 2007 May; 69(5):921-6. PMID: 17482935.
        View in: PubMed
      142. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane C, DuChane J, Carroll PR. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 2007 May 1; 109(9):1769-76. PMID: 17380491.
        View in: PubMed
      143. Joudi FN, Allareddy V, Kane C, Konety BR. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol. 2007 May; 177(5):1709-14. PMID: 17437791.
        View in: PubMed
      144. King CR, Freedland SJ, Terris MK, Aronson WJ, Kane C, Amling CL, Presti JC. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. Urology. 2007 Apr; 69(4):732-7. PMID: 17445660.
        View in: PubMed
      145. Freedland SJ, Kane C, Amling CL, Aronson WJ, Terris MK, Presti JC. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology. 2007 Mar; 69(3):495-9. PMID: 17382152.
        View in: PubMed
      146. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane C. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007 Mar; 177(3):883-7; discussion 887-8. PMID: 17296367.
        View in: PubMed
      147. Kane C, Presti JC, Amling CL, Aronson WJ, Terris MK, Freedland SJ. Changing nature of high risk patients undergoing radical prostatectomy. J Urol. 2007 Jan; 177(1):113-7. PMID: 17162017.
        View in: PubMed
      148. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane C, Penson DF, DuChane J, Carroll PR. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. PMID: 17141841.
        View in: PubMed
      149. Fitzsimons NJ, Presti JC, Kane C, Terris MK, Aronson WJ, Amling CL, Freedland SJ. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? J Urol. 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. PMID: 17085127.
        View in: PubMed
      150. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane C, Carroll PR. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006 Nov 15; 107(10):2384-91. PMID: 17039503.
        View in: PubMed
      151. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane C, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer. 2006 Sep 15; 107(6):1265-72. PMID: 16900523.
        View in: PubMed
      152. Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane C. Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol. 2006 Jul; 20(7):504-8. PMID: 16859465.
        View in: PubMed
      153. Ross PL, Meng MV, Kane C. Laparoscopic approaches to renal malignancies. Curr Probl Cancer. 2006 Jul-Aug; 30(4):168-93. PMID: 16860165.
        View in: PubMed
      154. Freedland SJ, Kane C, Amling CL, Aronson WJ, Presti JC, Terris MK. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. J Urol. 2006 Apr; 175(4):1298-302; discussion 1302-3. PMID: 16515984.
        View in: PubMed
      155. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 9; 354(6):557-66. PMID: 16467543.
        View in: PubMed
      156. Freedland SJ, Platz EA, Presti JC, Aronson WJ, Amling CL, Kane C, Terris MK. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol. 2006 Feb; 175(2):500-4; discussion 504. PMID: 16406980.
        View in: PubMed
      157. Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane C, Carroll PR, Igawa M, Dahiya R. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006 Jan 1; 106(1):79-86. PMID: 16323173.
        View in: PubMed
      158. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane C. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan; 175(1):125-9; discussion 129. PMID: 16406887.
        View in: PubMed
      159. Freedland SJ, Aronson WJ, Trock B, Cohen P, Kane C, Amling CL, Presti JC, Terris MK. Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomy. Clin Cancer Res. 2005 Nov 1; 11(21):7735-42. PMID: 16278394.
        View in: PubMed
      160. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane C. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. PMID: 16286124.
        View in: PubMed
      161. Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, Presti JC, Kane C. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol. 2005 Oct 20; 23(30):7546-54. PMID: 16234520.
        View in: PubMed
      162. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane C, Carroll PR, Igawa M, Dahiya R. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 2005 Oct 13; 24(45):6765-72. PMID: 16007175.
        View in: PubMed
      163. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane C, Carroll PR, Dahiya R. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6582-8. PMID: 16166436.
        View in: PubMed
      164. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane C, Carroll PR, Dahiya R. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer. 2005 Aug 20; 116(2):174-81. PMID: 15800905.
        View in: PubMed
      165. Master VA, Gottschalk AR, Kane C, Carroll PR. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. PMID: 16006867.
        View in: PubMed
      166. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane C, Carroll P, Dahiya R. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 1; 104(1):44-52. PMID: 15895377.
        View in: PubMed
      167. Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane C, Carroll PR. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol. 2005 Apr; 173(4):1126-31. PMID: 15758720.
        View in: PubMed
      168. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane C. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. PMID: 15758721.
        View in: PubMed
      169. Kane C, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. PMID: 15711258.
        View in: PubMed
      170. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane C, Carroll PR, Dahiya R. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):557-64. PMID: 15701841.
        View in: PubMed
      171. Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane C, Carroll PR, Dahiya R. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004 Dec 17; 325(3):934-42. PMID: 15541380.
        View in: PubMed
      172. Anast JW, Stoller ML, Meng MV, Master VA, Mitchell JA, Bassett WW, Kane C. Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. J Urol. 2004 Dec; 172(6 Pt 1):2287-91. PMID: 15538250.
        View in: PubMed
      173. Zhao H, Li LC, Okino ST, Kane C, Carroll PR, Dahiya R. Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol. 2004 Dec; 172(6 Pt 1):2344-6. PMID: 15538263.
        View in: PubMed
      174. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane C, Carroll PR, Dahiya R. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004 Sep 1; 64(17):5956-62. PMID: 15342374.
        View in: PubMed
      175. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane C, Carroll PR, Igawa M, Dahiya R. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):455-61. PMID: 15358197.
        View in: PubMed
      176. Freedland SJ, Aronson WJ, Kane C, Terris MK, Presti JC, Trock B, Amling CL. Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. Cancer. 2004 Aug 15; 101(4):748-53. PMID: 15305405.
        View in: PubMed
      177. Freedland SJ, Terris MK, Presti JC, Amling CL, Kane C, Trock B, Aronson WJ. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol. 2004 Aug; 172(2):520-4. PMID: 15247719.
        View in: PubMed
      178. Chen H, Ng V, Kane C, Russell IA. The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg. 2004 Aug; 99(2):357-9, table of contents. PMID: 15271705.
        View in: PubMed
      179. Freedland SJ, Terris MK, Csathy GS, Kane C, Amling CL, Presti JC, Dorey F, Aronson WJ. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol. 2004 Jun; 171(6 Pt 1):2215-20. PMID: 15126788.
        View in: PubMed
      180. Elliott SP, Gulati M, Pasta DJ, Spitalny GM, Kane C, Yee R, Lue TF. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology. 2004 Jun; 63(6):1148-52. PMID: 15183969.
        View in: PubMed
      181. Hittelman AB, Purohit RS, Kane C. Update of staging and risk assessment for prostate cancer patients. Curr Opin Urol. 2004 May; 14(3):163-70. PMID: 15069307.
        View in: PubMed
      182. Freedland SJ, Aronson WJ, Presti JC, Amling CL, Terris MK, Trock B, Kane C. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer. 2004 Apr 15; 100(8):1633-8. PMID: 15073850.
        View in: PubMed
      183. Freedland SJ, Presti JC, Kane C, Aronson WJ, Terris MK, Dorey F, Amling CL. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004 Mar; 63(3):518-22. PMID: 15028449.
        View in: PubMed
      184. Crain DS, Amling CL, Kane C. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol. 2004 Feb; 171(2 Pt 1):668-71. PMID: 14713783.
        View in: PubMed
      185. Kane C, Mitchell JA, Meng MV, Anast J, Carroll PR, Stoller ML. Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology. 2004 Feb; 63(2):241-6. PMID: 14972462.
        View in: PubMed
      186. Freedland SJ, Aronson WJ, Kane C, Presti JC, Amling CL, Elashoff D, Terris MK. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol. 2004 Feb 1; 22(3):446-53. PMID: 14691122.
        View in: PubMed
      187. Freedland SJ, Aronson WJ, Terris MK, Kane C, Amling CL, Dorey F, Presti JC. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer. 2003 Dec 1; 98(11):2344-50. PMID: 14635068.
        View in: PubMed
      188. Kane C, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003 Dec; 62(6):1035-9. PMID: 14665350.
        View in: PubMed
      189. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane C, Mehta SS, Carroll PR, Lubeck DP. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003 Nov; 170(5):1822-7. PMID: 14532784.
        View in: PubMed
      190. Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane C. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol. 2003 Sep; 170(3):905-8. PMID: 12913727.
        View in: PubMed
      191. Freedland SJ, Presti JC, Terris MK, Kane C, Aronson WJ, Dorey F, Amling CL. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol. 2003 Jun; 169(6):2129-35. PMID: 12771734.
        View in: PubMed
      192. Freedland SJ, Aronson WJ, Terris MK, Kane C, Amling CL, Dorey F, Presti JC. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol. 2003 Jun; 169(6):2136-41. PMID: 12771735.
        View in: PubMed
      193. Freedland SJ, Aronson W, Presti JC, Kane C, Terris MK, Elashoff D, Amling CL. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. J Urol. 2003 Jun; 169(6):2142-6. PMID: 12771736.
        View in: PubMed
      194. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane C, Dahiya R. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res. 2003 Jun; 9(6):2121-32. PMID: 12796377.
        View in: PubMed
      195. Yun EJ, Yeh BM, Yabes AP, Coakley FV, Kane C. Erdheim-Chester disease: case report and review of associated urological, radiological and histological features. J Urol. 2003 Apr; 169(4):1470-1. PMID: 12629387.
        View in: PubMed
      196. Freedland SJ, Presti JC, Amling CL, Kane C, Aronson WJ, Dorey F, Terris MK. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology. 2003 Apr; 61(4):736-41. PMID: 12670557.
        View in: PubMed
      197. Freedland SJ, Aronson WJ, Csathy GS, Kane C, Amling CL, Presti JC, Dorey F, Terris MK. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology. 2003 Apr; 61(4):742-7. PMID: 12670558.
        View in: PubMed
      198. Johnstone PA, Riffenburgh RH, Moul JW, Sun L, Wu H, McLeod DG, Kane C, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Chung A, Soderdahl D, Do J, Amling CL. Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):964-9. PMID: 12605974.
        View in: PubMed
      199. Freedland SJ, Kane C, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. J Urol. 2003 Mar; 169(3):969-73. PMID: 12576824.
        View in: PubMed
      200. Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology. 2003 Mar; 61(3):589-95. PMID: 12639653.
        View in: PubMed
      201. Kane C, Amling CL, Johnstone PA, Pak N, Lance RS, Thrasher JB, Foley JP, Riffenburgh RH, Moul JW. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology. 2003 Mar; 61(3):607-11. PMID: 12639656.
        View in: PubMed
      202. Li LC, Zhao H, Shiina H, Kane C, Dahiya R. PGDB: a curated and integrated database of genes related to the prostate. Nucleic Acids Res. 2003 Jan 1; 31(1):291-3. PMID: 12520005.
        View in: PubMed
      203. Gray Sears CL, Ward JF, Sears ST, Puckett MF, Kane C, Amling CL. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002 Dec; 168(6):2457-60. PMID: 12441939.
        View in: PubMed
      204. Johnstone PA, Kane C, Sun L, Wu H, Moul JW, McLeod DG, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Baldwin D, Soderdahl D, Do J, Amling CL. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002 Nov; 225(2):420-6. PMID: 12409575.
        View in: PubMed
      205. Freedland SJ, Amling CL, Dorey F, Kane C, Presti JC, Terris MK, Aronson WJ. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology. 2002 Oct; 60(4):670-4. PMID: 12385931.
        View in: PubMed
      206. Kane C, Tarman GJ, Summerton DJ, Buchmann CE, Ward JF, O'Reilly KJ, Ruiz H, Thrasher JB, Zorn B, Smith C, Morey AF. Multi-institutional experience with buccal mucosa onlay urethroplasty for bulbar urethral reconstruction. J Urol. 2002 Mar; 167(3):1314-7. PMID: 11832721.
        View in: PubMed
      207. Downs TM, Kane C, Grossfeld GD, Meng MV, Carroll PR. Surgery for prostate cancer: rationale, technique and outcomes. Cancer Metastasis Rev. 2002; 21(1):29-44. PMID: 12400995.
        View in: PubMed